| Analysis | Samples | Factors | Units |
|---|---|---|---|
| HILIC NEGATIVE ION MODE | 10_NC_12h_1 | hours:12 | Doxorubicin dosage(μM):- | Peak area normalized |
| HILIC NEGATIVE ION MODE | 10_NC_12h_2 | hours:12 | Doxorubicin dosage(μM):- | Peak area normalized |
| HILIC NEGATIVE ION MODE | 10_NC_12h_3 | hours:12 | Doxorubicin dosage(μM):- | Peak area normalized |
| HILIC NEGATIVE ION MODE | 10_NC_12h_4 | hours:12 | Doxorubicin dosage(μM):- | Peak area normalized |
| HILIC NEGATIVE ION MODE | 10_NC_12h_5 | hours:12 | Doxorubicin dosage(μM):- | Peak area normalized |
| HILIC NEGATIVE ION MODE | 10_12h_1 | hours:12 | Doxorubicin dosage(μM):10 | Peak area normalized |
| HILIC NEGATIVE ION MODE | 10_12h_2 | hours:12 | Doxorubicin dosage(μM):10 | Peak area normalized |
| HILIC NEGATIVE ION MODE | 10_12h_3 | hours:12 | Doxorubicin dosage(μM):10 | Peak area normalized |
| HILIC NEGATIVE ION MODE | 10_12h_4 | hours:12 | Doxorubicin dosage(μM):10 | Peak area normalized |
| HILIC NEGATIVE ION MODE | 10_12h_5 | hours:12 | Doxorubicin dosage(μM):10 | Peak area normalized |
| HILIC NEGATIVE ION MODE | 0.1_NC_24h_1 | hours:24 | Doxorubicin dosage(μM):- | Peak area normalized |
| HILIC NEGATIVE ION MODE | 0.1_NC_24h_2 | hours:24 | Doxorubicin dosage(μM):- | Peak area normalized |
| HILIC NEGATIVE ION MODE | 0.1_NC_24h_3 | hours:24 | Doxorubicin dosage(μM):- | Peak area normalized |
| HILIC NEGATIVE ION MODE | 0.1_NC_24h_4 | hours:24 | Doxorubicin dosage(μM):- | Peak area normalized |
| HILIC NEGATIVE ION MODE | 0.1_NC_24h_5 | hours:24 | Doxorubicin dosage(μM):- | Peak area normalized |
| HILIC NEGATIVE ION MODE | 10_NC_24h_1 | hours:24 | Doxorubicin dosage(μM):- | Peak area normalized |
| HILIC NEGATIVE ION MODE | 10_NC_24h_2 | hours:24 | Doxorubicin dosage(μM):- | Peak area normalized |
| HILIC NEGATIVE ION MODE | 10_NC_24h_3 | hours:24 | Doxorubicin dosage(μM):- | Peak area normalized |
| HILIC NEGATIVE ION MODE | 10_NC_24h_4 | hours:24 | Doxorubicin dosage(μM):- | Peak area normalized |
| HILIC NEGATIVE ION MODE | 10_NC_24h_5 | hours:24 | Doxorubicin dosage(μM):- | Peak area normalized |
| HILIC NEGATIVE ION MODE | 0.1_24h_1 | hours:24 | Doxorubicin dosage(μM):0.1 | Peak area normalized |
| HILIC NEGATIVE ION MODE | 0.1_24h_2 | hours:24 | Doxorubicin dosage(μM):0.1 | Peak area normalized |
| HILIC NEGATIVE ION MODE | 0.1_24h_3 | hours:24 | Doxorubicin dosage(μM):0.1 | Peak area normalized |
| HILIC NEGATIVE ION MODE | 0.1_24h_4 | hours:24 | Doxorubicin dosage(μM):0.1 | Peak area normalized |
| HILIC NEGATIVE ION MODE | 0.1_24h_5 | hours:24 | Doxorubicin dosage(μM):0.1 | Peak area normalized |
| HILIC NEGATIVE ION MODE | 10_24h_1 | hours:24 | Doxorubicin dosage(μM):10 | Peak area normalized |
| HILIC NEGATIVE ION MODE | 10_24h_2 | hours:24 | Doxorubicin dosage(μM):10 | Peak area normalized |
| HILIC NEGATIVE ION MODE | 10_24h_3 | hours:24 | Doxorubicin dosage(μM):10 | Peak area normalized |
| HILIC NEGATIVE ION MODE | 10_24h_4 | hours:24 | Doxorubicin dosage(μM):10 | Peak area normalized |
| HILIC NEGATIVE ION MODE | 10_24h_5 | hours:24 | Doxorubicin dosage(μM):10 | Peak area normalized |
| HILIC NEGATIVE ION MODE | 10_NC_36h_1 | hours:36 | Doxorubicin dosage(μM):- | Peak area normalized |
| HILIC NEGATIVE ION MODE | 10_NC_36h_2 | hours:36 | Doxorubicin dosage(μM):- | Peak area normalized |
| HILIC NEGATIVE ION MODE | 10_NC_36h_3 | hours:36 | Doxorubicin dosage(μM):- | Peak area normalized |
| HILIC NEGATIVE ION MODE | 10_NC_36h_4 | hours:36 | Doxorubicin dosage(μM):- | Peak area normalized |
| HILIC NEGATIVE ION MODE | 10_NC_36h_5 | hours:36 | Doxorubicin dosage(μM):- | Peak area normalized |
| HILIC NEGATIVE ION MODE | 10_36h_1 | hours:36 | Doxorubicin dosage(μM):10 | Peak area normalized |
| HILIC NEGATIVE ION MODE | 10_36h_2 | hours:36 | Doxorubicin dosage(μM):10 | Peak area normalized |
| HILIC NEGATIVE ION MODE | 10_36h_3 | hours:36 | Doxorubicin dosage(μM):10 | Peak area normalized |
| HILIC NEGATIVE ION MODE | 10_36h_4 | hours:36 | Doxorubicin dosage(μM):10 | Peak area normalized |
| HILIC NEGATIVE ION MODE | 10_36h_5 | hours:36 | Doxorubicin dosage(μM):10 | Peak area normalized |
| HILIC NEGATIVE ION MODE | 0.1_NC_48h_1 | hours:48 | Doxorubicin dosage(μM):- | Peak area normalized |
| HILIC NEGATIVE ION MODE | 0.1_NC_48h_2 | hours:48 | Doxorubicin dosage(μM):- | Peak area normalized |
| HILIC NEGATIVE ION MODE | 0.1_NC_48h_3 | hours:48 | Doxorubicin dosage(μM):- | Peak area normalized |
| HILIC NEGATIVE ION MODE | 0.1_NC_48h_4 | hours:48 | Doxorubicin dosage(μM):- | Peak area normalized |
| HILIC NEGATIVE ION MODE | 0.1_NC_48h_5 | hours:48 | Doxorubicin dosage(μM):- | Peak area normalized |
| HILIC NEGATIVE ION MODE | 10_NC_48h_1 | hours:48 | Doxorubicin dosage(μM):- | Peak area normalized |
| HILIC NEGATIVE ION MODE | 10_NC_48h_2 | hours:48 | Doxorubicin dosage(μM):- | Peak area normalized |
| HILIC NEGATIVE ION MODE | 10_NC_48h_3 | hours:48 | Doxorubicin dosage(μM):- | Peak area normalized |
| HILIC NEGATIVE ION MODE | 10_NC_48h_4 | hours:48 | Doxorubicin dosage(μM):- | Peak area normalized |
| HILIC NEGATIVE ION MODE | 10_NC_48h_5 | hours:48 | Doxorubicin dosage(μM):- | Peak area normalized |
| HILIC NEGATIVE ION MODE | 0.1_48h_1 | hours:48 | Doxorubicin dosage(μM):0.1 | Peak area normalized |
| HILIC NEGATIVE ION MODE | 0.1_48h_2 | hours:48 | Doxorubicin dosage(μM):0.1 | Peak area normalized |
| HILIC NEGATIVE ION MODE | 0.1_48h_3 | hours:48 | Doxorubicin dosage(μM):0.1 | Peak area normalized |
| HILIC NEGATIVE ION MODE | 0.1_48h_4 | hours:48 | Doxorubicin dosage(μM):0.1 | Peak area normalized |
| HILIC NEGATIVE ION MODE | 0.1_48h_5 | hours:48 | Doxorubicin dosage(μM):0.1 | Peak area normalized |
| HILIC NEGATIVE ION MODE | 10_48h_1 | hours:48 | Doxorubicin dosage(μM):10 | Peak area normalized |
| HILIC NEGATIVE ION MODE | 10_48h_2 | hours:48 | Doxorubicin dosage(μM):10 | Peak area normalized |
| HILIC NEGATIVE ION MODE | 10_48h_3 | hours:48 | Doxorubicin dosage(μM):10 | Peak area normalized |
| HILIC NEGATIVE ION MODE | 10_48h_4 | hours:48 | Doxorubicin dosage(μM):10 | Peak area normalized |
| HILIC NEGATIVE ION MODE | 10_48h_5 | hours:48 | Doxorubicin dosage(μM):10 | Peak area normalized |
| HILIC NEGATIVE ION MODE | 0.1_NC_72h_1 | hours:72 | Doxorubicin dosage(μM):- | Peak area normalized |
| HILIC NEGATIVE ION MODE | 0.1_NC_72h_2 | hours:72 | Doxorubicin dosage(μM):- | Peak area normalized |
| HILIC NEGATIVE ION MODE | 0.1_NC_72h_3 | hours:72 | Doxorubicin dosage(μM):- | Peak area normalized |
| HILIC NEGATIVE ION MODE | 0.1_NC_72h_4 | hours:72 | Doxorubicin dosage(μM):- | Peak area normalized |
| HILIC NEGATIVE ION MODE | 0.1_NC_72h_5 | hours:72 | Doxorubicin dosage(μM):- | Peak area normalized |
| HILIC NEGATIVE ION MODE | 0.1_72h_1 | hours:72 | Doxorubicin dosage(μM):0.1 | Peak area normalized |
| HILIC NEGATIVE ION MODE | 0.1_72h_2 | hours:72 | Doxorubicin dosage(μM):0.1 | Peak area normalized |
| HILIC NEGATIVE ION MODE | 0.1_72h_3 | hours:72 | Doxorubicin dosage(μM):0.1 | Peak area normalized |
| HILIC NEGATIVE ION MODE | 0.1_72h_4 | hours:72 | Doxorubicin dosage(μM):0.1 | Peak area normalized |
| HILIC NEGATIVE ION MODE | 0.1_72h_5 | hours:72 | Doxorubicin dosage(μM):0.1 | Peak area normalized |
| HILIC NEGATIVE ION MODE | 0.1_NC_96h_1 | hours:96 | Doxorubicin dosage(μM):- | Peak area normalized |
| HILIC NEGATIVE ION MODE | 0.1_NC_96h_2 | hours:96 | Doxorubicin dosage(μM):- | Peak area normalized |
| HILIC NEGATIVE ION MODE | 0.1_NC_96h_3 | hours:96 | Doxorubicin dosage(μM):- | Peak area normalized |
| HILIC NEGATIVE ION MODE | 0.1_NC_96h_4 | hours:96 | Doxorubicin dosage(μM):- | Peak area normalized |
| HILIC NEGATIVE ION MODE | 0.1_NC_96h_5 | hours:96 | Doxorubicin dosage(μM):- | Peak area normalized |
| HILIC NEGATIVE ION MODE | 0.1_96h_1 | hours:96 | Doxorubicin dosage(μM):0.1 | Peak area normalized |
| HILIC NEGATIVE ION MODE | 0.1_96h_2 | hours:96 | Doxorubicin dosage(μM):0.1 | Peak area normalized |
| HILIC NEGATIVE ION MODE | 0.1_96h_3 | hours:96 | Doxorubicin dosage(μM):0.1 | Peak area normalized |
| HILIC NEGATIVE ION MODE | 0.1_96h_4 | hours:96 | Doxorubicin dosage(μM):0.1 | Peak area normalized |
| HILIC NEGATIVE ION MODE | 0.1_96h_5 | hours:96 | Doxorubicin dosage(μM):0.1 | Peak area normalized |
Return to study ST001170 main page
Download data matrix(Timecourse on MCF-7 cells treated with different concentration of doxorubicin HILIC NEGATIVE ION MODE)
- Metabolomics Workbench
|